Leflunomide Tablet
Product Images NDC 50268-477

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 50268-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (477 15 10mg)

10 (477 15 10mg)
Leflunomide Tablets, USP is a prescription medicine that comes in a pack of 50 tablets (5 x 10) unit dose. Each tablet contains 10 mg of leflunomide. It is recommended to be stored at a temperature of 25°C (77°F) with excursions allowed from 15° to 30°C (59° to 86°F). It should be protected from light. The usual dosage is mentioned in the package insert. The medicine is manufactured for AvKARE, Pulaski, TN 38478.*
FDA Label Image

20 (478 15 20mg)

20 (478 15 20mg)
This is a description of Leflunomide tablets, a prescription medicine that contains 20mg of the active ingredient. The tablets are available in a package of 50 units, each containing 10 tablets. The tablets should be stored at a temperature range of 15° to 30°C and protected from light. The package insert should be consulted for dosage information. The tablets are manufactured for AVKARE, and the label includes a lot number and a manufacturing date.*
FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
The text describes the percentage of responders in trial 1 for ACR (American College of Rheumatology) over the course of 6 months. There is a chart displaying the percentage of responders over time. There are four treatment groups represented by the abbreviations "pL", "NTX", "4", and "LEF". It is unclear what these treatments refer to without additional context. The method of calculation is last observation carried forward.*
FDA Label Image

Figure3.jpg (Figure3)

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Structure1.jpg (Structure1)

FDA Label Image

Structure2.jpg (Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.